Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

NCT01077544

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Novartis Investigative Site Bordeaux, Aquitaine, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Poitiers, France
View Trial Details
Completed

A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02729896

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UCLA Los Angeles, California, United States
  • University Miami Miami, Florida, United States
  • Stony Brook University Hospital Stony Brook, New York, United States
  • Columbia Basin Hem-Onc; Department Hematology Oncology Kennewick, Washington, United States
View all 19 locations
View Trial Details
Completed

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

NCT00885196

Conditions
Dermatitis, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Belleair Research Center, LLC Pinellas Park, Florida, United States
  • Kansas City Dermatology, PA Overland Park, Kansas, United States
  • Dermatology Specialists Louisville, Kentucky, United States
View all 40 locations
View Trial Details
Completed

Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.

NCT02227433

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Irccs Centro Di Riferimento Oncologico Di Aviano (Pn) Aviano, Italia, Italy
  • Policlinico S.Orsola Malpighi Bologna, Italy
  • Irccs Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Di Napoli Naples, Italy
View Trial Details
Completed

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

NCT00424983

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +18 more
Locations
  • Oncotherapeutics West Hollywood, California, United States
  • Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00622258

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Isehara, Kanagawa, Japan
View Trial Details

Related conditions